Viking Therapeutics
VKTX
$76.97
Share price
1.60%
Change (1 day)
255.19%
Change (1 year)
Categories
EPS for Viking Therapeutics (VKTX)
EPS in 2023 (TTM): -$0.93
According to Viking Therapeutics 's latest financial reports the company's current EPS (TTM) is -$0.93. In 2022 the company made an earnings per share (EPS) of -$0.91 a decrease over its 2021 EPS that were of -$0.72.
EPS history for Viking Therapeutics from 2014 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -$0.93 | 2.2% |
| 2022 | -$0.91 | 26.39% |
| 2021 | -$0.72 | 33.33% |
| 2020 | -$0.54 | 45.95% |
| 2019 | -$0.37 | -5.13% |
| 2018 | -$0.39 | -51.25% |
| 2017 | -$0.80 | -20% |
| 2016 | -$1.00 | -64.08% |
| 2015 | -$2.78 | -45.17% |
| 2014 | -$5.08 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 Ultragenyx RARE | -$10.24 | 1,001.08% | 🇺🇸 USA |
 Repligen
RGEN | $2.09 | -324.73% | 🇺🇸 USA |